Early discharge for low-risk pediatric febrile neutropenia: safe only in selected centers

Area of Science:

• Pediatric Oncology
• Hematology
• Infectious Diseases

Background:

• Fever and neutropenia (FN) in pediatric oncology patients often leads to hospitalization.
• Step-down pathways for low-risk FN patients aim to reduce hospital stays and healthcare costs.
• Marathe et al. reported positive outcomes with an early discharge pathway for low-risk FN patients.

Purpose of the Study:

• To critically evaluate the universal applicability of early discharge pathways for pediatric oncology patients with low-risk fever and neutropenia.
• To identify essential healthcare infrastructure components necessary for the safe implementation of such pathways.
• To discuss the challenges and considerations for equitable adoption in diverse healthcare settings.

Main Methods:

• This is an Article Commentary, not a primary research study.
• It analyzes existing literature and clinical practice considerations.
• It uses a case perspective from eastern Türkiye to illustrate implementation challenges.

Main Results:

• Early discharge pathways can reduce hospitalization for low-risk FN patients.
• Pathway safety is contingent upon critical healthcare infrastructure, including rapid microbiology, timely antibiotics, 24-hour oncology consultation, and reliable reassessment.
• Implementation challenges are significant in resource-limited or geographically remote settings.

Conclusions:

• Early discharge is not universally applicable without considering the specific healthcare infrastructure.
• Defining auditable infrastructure thresholds is crucial for safe and equitable implementation.
• Future guidelines should incorporate infrastructure requirements alongside clinical outcomes to prevent risk shifting.